A detailed history of Rovin Capital transactions in Pfizer Inc stock. As of the latest transaction made, Rovin Capital holds 27,461 shares of PFE stock, worth $707,669. This represents 0.29% of its overall portfolio holdings.

Number of Shares
27,461
Previous 23,322 17.75%
Holding current value
$707,669
Previous $653,000 21.75%
% of portfolio
0.29%
Previous 0.27%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$27.7 - $31.39 $114,650 - $129,923
4,139 Added 17.75%
27,461 $795,000
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $92,249 - $108,099
3,652 Added 18.57%
23,322 $653,000
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $99,987 - $114,817
3,862 Added 24.43%
19,670 $546,000
Q4 2023

Mar 12, 2024

BUY
$26.13 - $33.94 $38,594 - $50,129
1,477 Added 10.31%
15,808 $455,000
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $191,801 - $224,197
5,977 Added 71.55%
14,331 $475,000
Q2 2023

Aug 08, 2023

BUY
$36.12 - $41.79 $301,746 - $349,113
8,354 New
8,354 $306,000
Q1 2022

Jun 13, 2022

SELL
$45.75 - $56.69 $465,918 - $577,330
-10,184 Closed
0 $0
Q4 2021

Feb 24, 2022

BUY
$41.32 - $61.25 $420,802 - $623,770
10,184 New
10,184 $601,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Rovin Capital Portfolio

Follow Rovin Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rovin Capital , based on Form 13F filings with the SEC.

News

Stay updated on Rovin Capital with notifications on news.